England leads in offering 'Trojan horse' drug to blood cancer patients
Technology
England is rolling out a new "Trojan horse" treatment for multiple myeloma, using the drug Blenrep to sneak a toxic payload into cancer cells and wipe them out. This breakthrough could help about 1,500 people each year.
Helps patients live longer, keeps disease from progressing
Blenrep is given with other meds (like bortezomib or pomalidomide plus dexamethasone) to adults whose cancer has come back after earlier treatments. Recent trials found it helps patients live longer and keeps the disease from progressing better than some current options.
Targeted approach is raising the bar for treating tough cases
Blenrep targets a marker on myeloma cells (BCMA) and delivers a powerful anti-cancer agent right where it's needed. This targeted approach is raising the bar for treating tough cases of multiple myeloma.